Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Thats why we love that Medvi offers 24/7 support
:max_bytes(150000):strip_icc()/Health-GettyImages-2253438005-Exported-0b4e8bc256fc464297ff339a24dd8d60.jpg)
Shintani T, Sakoguchi H, Yoshihara A, Izumori K, Sato M
Tirzepatide starts at 2.5 mg weekly (Mounjaro), increasing by 2.5 mg every 4 weeks until the desired maintenance dose (up to 15 mg ) is reached
Brown, Patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias should not take Zepbound. Additionally, patients with pancreatitis, severe gastrointestinal disease, kidney disease, gallbladder disease, or cirrhosis should discuss the risks of taking Zepbound with their healthcare provider
US$ 29.89
/product/64/6545723/1.jpg?5558)
US$ 29.30
US$ 24.93
US$ 21.24
